Nowe badania leku Campath. Brzmią obiecująco…
'Rebooting' MS Drug Succeeds In Trials
www.medicalnewstoday.com
Two phase 3 trials of a drug for treating multiple sclerosis (MS) that reboots the immune system showed it to be effective in patients who had not responded to first-line therapy: it reduced
